Literature DB >> 28130021

Precision Medicine Requires Precision Laboratories.

Mangalathu S Rajeevan1, Tengguo Li1, Elizabeth R Unger2.   

Abstract

This commentary highlights the validation study by Lih et al that supports the use of precision medicine for improved clinical trials. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2017        PMID： 28130021      PMCID： PMC5504402          DOI： 10.1016/j.jmoldx.2017.01.001

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.568


  11 in total

1.  Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.

Authors:  Chih-Jian Lih; Robin D Harrington; David J Sims; Kneshay N Harper; Courtney H Bouk; Vivekananda Datta; Jonathan Yau; Rajesh R Singh; Mark J Routbort; Rajyalakshmi Luthra; Keyur P Patel; Geeta S Mantha; Savitri Krishnamurthy; Karyn Ronski; Zenta Walther; Karin E Finberg; Sandra Canosa; Hayley Robinson; Amelia Raymond; Long P Le; Lisa M McShane; Eric C Polley; Barbara A Conley; James H Doroshow; A John Iafrate; Jeffrey L Sklar; Stanley R Hamilton; P Mickey Williams
Journal:  J Mol Diagn       Date:  2017-02-07       Impact factor: 5.568

2.  College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.

Authors:  Nazneen Aziz; Qin Zhao; Lynn Bry; Denise K Driscoll; Birgit Funke; Jane S Gibson; Wayne W Grody; Madhuri R Hegde; Gerald A Hoeltge; Debra G B Leonard; Jason D Merker; Rakesh Nagarajan; Linda A Palicki; Ryan S Robetorye; Iris Schrijver; Karen E Weck; Karl V Voelkerding
Journal:  Arch Pathol Lab Med       Date:  2014-08-25       Impact factor: 5.534

3.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

Authors:  Donavan T Cheng; Talia N Mitchell; Ahmet Zehir; Ronak H Shah; Ryma Benayed; Aijazuddin Syed; Raghu Chandramohan; Zhen Yu Liu; Helen H Won; Sasinya N Scott; A Rose Brannon; Catherine O'Reilly; Justyna Sadowska; Jacklyn Casanova; Angela Yannes; Jaclyn F Hechtman; Jinjuan Yao; Wei Song; Dara S Ross; Alifya Oultache; Snjezana Dogan; Laetitia Borsu; Meera Hameed; Khedoudja Nafa; Maria E Arcila; Marc Ladanyi; Michael F Berger
Journal:  J Mol Diagn       Date:  2015-03-20       Impact factor: 5.568

Review 4.  Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.

Authors:  Keith T Schmidt; Cindy H Chau; Douglas K Price; William D Figg
Journal:  J Clin Pharmacol       Date:  2016-06-17       Impact factor: 3.126

5.  Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.

Authors:  Rajesh R Singh; Keyur P Patel; Mark J Routbort; Neelima G Reddy; Bedia A Barkoh; Brian Handal; Rashmi Kanagal-Shamanna; Wesley O Greaves; L Jeffrey Medeiros; Kenneth D Aldape; Rajyalakshmi Luthra
Journal:  J Mol Diagn       Date:  2013-06-26       Impact factor: 5.568

6.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Authors:  Garrett M Frampton; Alex Fichtenholtz; Geoff A Otto; Kai Wang; Sean R Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lazaro Garcia; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A Rubin; Snjezana Dogan; Cyrus V Hedvat; Michael F Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A Miller; Jeffrey S Ross; John Curran; Maureen T Cronin; Philip J Stephens; Doron Lipson; Roman Yelensky
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

7.  Assuring the quality of next-generation sequencing in clinical laboratory practice.

Authors:  Amy S Gargis; Lisa Kalman; Meredith W Berry; David P Bick; David P Dimmock; Tina Hambuch; Fei Lu; Elaine Lyon; Karl V Voelkerding; Barbara A Zehnbauer; Richa Agarwala; Sarah F Bennett; Bin Chen; Ephrem L H Chin; John G Compton; Soma Das; Daniel H Farkas; Matthew J Ferber; Birgit H Funke; Manohar R Furtado; Lilia M Ganova-Raeva; Ute Geigenmüller; Sandra J Gunselman; Madhuri R Hegde; Philip L F Johnson; Andrew Kasarskis; Shashikant Kulkarni; Thomas Lenk; C S Jonathan Liu; Megan Manion; Teri A Manolio; Elaine R Mardis; Jason D Merker; Mangalathu S Rajeevan; Martin G Reese; Heidi L Rehm; Birgitte B Simen; Joanne M Yeakley; Justin M Zook; Ira M Lubin
Journal:  Nat Biotechnol       Date:  2012-11       Impact factor: 54.908

Review 8.  Is the NCI MATCH trial a match for gynecologic oncology?

Authors:  Kathleen N Moore; Robert S Mannel
Journal:  Gynecol Oncol       Date:  2015-11-14       Impact factor: 5.482

9.  ACMG clinical laboratory standards for next-generation sequencing.

Authors:  Heidi L Rehm; Sherri J Bale; Pinar Bayrak-Toydemir; Jonathan S Berg; Kerry K Brown; Joshua L Deignan; Michael J Friez; Birgit H Funke; Madhuri R Hegde; Elaine Lyon
Journal:  Genet Med       Date:  2013-07-25       Impact factor: 8.822

10.  Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.

Authors:  Daniel H Hovelson; Andrew S McDaniel; Andi K Cani; Bryan Johnson; Kate Rhodes; Paul D Williams; Santhoshi Bandla; Geoffrey Bien; Paul Choppa; Fiona Hyland; Rajesh Gottimukkala; Guoying Liu; Manimozhi Manivannan; Jeoffrey Schageman; Efren Ballesteros-Villagrana; Catherine S Grasso; Michael J Quist; Venkata Yadati; Anmol Amin; Javed Siddiqui; Bryan L Betz; Karen E Knudsen; Kathleen A Cooney; Felix Y Feng; Michael H Roh; Peter S Nelson; Chia-Jen Liu; David G Beer; Peter Wyngaard; Arul M Chinnaiyan; Seth Sadis; Daniel R Rhodes; Scott A Tomlins
Journal:  Neoplasia       Date:  2015-04       Impact factor: 5.715
View more
  1 in total

1.  Evaluation of Commercial Next-Generation Sequencing Bioinformatics Software Solutions.

Authors:  Rama R Gullapalli
Journal:  J Mol Diagn       Date:  2019-11-18       Impact factor: 5.568
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.